Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 23Recruiting 8Unknown 4Terminated 4Withdrawn 2Active not recruiting 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Motor Activity 2Polycystic Ovary Syndrome 1Insulin Resistance 1Breast Neoplasms 1

Interventions

pembrolizumab 439Carboplatin 322Nivolumab 298Cyclophosphamide 286Specimen Handling 271Magnetic Resonance Spectroscopy 259Cisplatin 250Paclitaxel 249Radiotherapy 230Dexamethasone 184Biopsy 182Gemcitabine 180durvalumab 171atezolizumab 152Doxorubicin 141Rituximab 138Lenalidomide 136Ipilimumab 134Docetaxel 132Bevacizumab 132Radiation 121Capecitabine 120Oxaliplatin 116Etoposide 116Radiosurgery 113Fluorouracil 112Pemetrexed 109fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × High-Intensity Interval Training × Clear all
NCT06190600 2025-04-30

SPORTNATHy

The Greater Poland Cancer Centre

Phase NA Active not recruiting
40 enrolled
Breast

Breast Neoplasms, Motor Activity

NCT02303470 2024-06-20

PCOS & Insulin Resistance Exercise Study

University of California, San Francisco

Phase NA Active not recruiting
47 enrolled

Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡